ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

CDC To Award $23 Mil. To States for Screening

April 26, 1991

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998